EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells (ATAC-seq)
Ontology highlight
ABSTRACT: EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells (ATAC-seq)
PROVIDER: PRJNA1030764 | ENA |
REPOSITORIES: ENA
ACCESS DATA